Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - STOCK-BASED COMPENSATION
Stock-based Compensation NBIX - Neurocrine Biosciences, Inc.
194 M
LAST VALUE
20.33%
2 YEAR CAGR
27.32%
5 YEAR CAGR
39.79%
10 YEAR CAGR